- Home
- MCI
as 11-15-2024 4:00pm EST
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. These investments are typically made to small or middle market companies. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 400.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 40.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.96 - $19.24 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Barings Corporate Investors News
MCI Breaking Stock News: Dive into MCI Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Barings Corporate Investors Reports Preliminary Third Quarter 2024 Results
Business Wire
a month ago
Barings Corporate Investors Announces Quarterly Cash Dividend Of $0.40 Per Share
Business Wire
3 months ago
Barings Corporate Investors Reports Preliminary Second Quarter 2024 Results and Announces Increased Quarterly Cash Dividend Of $0.40 Per Share
CNW Group
5 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
PR Newswire
5 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Business Wire
5 months ago
Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
AFP
5 months ago
New Zealand scraps plan to tax livestock burps, farts
Business Wire
5 months ago
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
Compare MCI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MCI Barings Corporate Investors - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.